BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schoepfer A, Santos J, Fournier N, Schibli S, Spalinger J, Vavricka S, Safroneeva E, Aslan N, Rogler G, Braegger C, Nydegger A. Systematic Analysis of the Impact of Diagnostic Delay on Bowel Damage in Paediatric Versus Adult Onset Crohn’s Disease. Journal of Crohn's and Colitis 2019;13:1334-42. [DOI: 10.1093/ecco-jcc/jjz065] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Pugliese D, Papi C, Privitera G, Aratari A, Festa S, Armuzzi A. The management of inflammatory bowel diseases in the era of COVID-19 pandemic: When "non-urgent" does not mean "deferrable". Dig Liver Dis 2020;52:1238-40. [PMID: 32601025 DOI: 10.1016/j.dld.2020.05.053] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Singh H, Nguyen T, Pho C, Giles E. Early Infliximab in Crohn's is associated with decreased intestinal surgery and similar health care costs. Scand J Gastroenterol 2021;56:397-402. [PMID: 33595389 DOI: 10.1080/00365521.2021.1880626] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Agrawal M, Spencer EA, Colombel JF, Ungaro RC. Approach to the Management of Recently Diagnosed Inflammatory Bowel Disease Patients: A User's Guide for Adult and Pediatric Gastroenterologists. Gastroenterology 2021;161:47-65. [PMID: 33940007 DOI: 10.1053/j.gastro.2021.04.063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhu M, Feng Q, Xu X, Qiao Y, Cui Z, Yan Y, Ran Z. Efficacy of early intervention on the bowel damage and intestinal surgery of Crohn's disease, based on the Lémann index. BMC Gastroenterol 2020;20:421. [PMID: 33308166 DOI: 10.1186/s12876-020-01575-7] [Reference Citation Analysis]
5 Martín-de-Carpi J, Jiménez Treviño S, Pujol Muncunill G, Martín-Masot R, Navas-López VM. [Time to diagnosis in paediatric inflammatory bowel disease: Key points for an early diagnosis]. An Pediatr (Engl Ed) 2020;92:242.e1-9. [PMID: 31883747 DOI: 10.1016/j.anpedi.2019.11.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Ricciuto A, Mack DR, Huynh HQ, Jacobson K, Otley AR, deBruyn J, El-Matary W, Deslandres C, Sherlock ME, Critch JN, Bax K, Jantchou P, Seidman EG, Carman N, Rashid M, Muise A, Wine E, Carroll MW, Lawrence S, Van Limbergen J, Benchimol EI, Walters TD, Griffiths AM, Church PC. Diagnostic Delay Is Associated With Complicated Disease and Growth Impairment in Paediatric Crohn's Disease. J Crohns Colitis 2021;15:419-31. [PMID: 32978629 DOI: 10.1093/ecco-jcc/jjaa197] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Wang H, Wu Y, Ye C, Liu Z, Wang X. Perianal disease onset age is associated with distinct disease features and need for intestinal resection in perianal Crohn's disease: a ten-year hospital-based observational study in China. BMC Gastroenterol 2021;21:376. [PMID: 34649523 DOI: 10.1186/s12876-021-01961-9] [Reference Citation Analysis]
8 Ananthakrishnan AN, Kaplan GG, Ng SC. Changing Global Epidemiology of Inflammatory Bowel Diseases: Sustaining Health Care Delivery Into the 21st Century. Clinical Gastroenterology and Hepatology 2020;18:1252-60. [DOI: 10.1016/j.cgh.2020.01.028] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 19.0] [Reference Citation Analysis]
9 Zhu M, Xu X, Feng Q, Cui Z, Wang T, Yan Y, Ran Z. Effectiveness of Infliximab on Deep Radiological Remission in Chinese Patients with Perianal Fistulizing Crohn's Disease. Dig Dis Sci. 2021;66:1658-1668. [PMID: 32524415 DOI: 10.1007/s10620-020-06398-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
10 Chen BX, Han ZM, Zhou Q, Liu HB, Xu PC, Zhi FC. Efficacy of infliximab in treatment-naïve patients with stricturing small bowel Crohn's disease. Scand J Gastroenterol 2021;56:812-9. [PMID: 33962533 DOI: 10.1080/00365521.2021.1922748] [Reference Citation Analysis]
11 Zilbauer M, Heuschkel R. Disease Prognostic Biomarkers in Inflammatory Bowel Diseases—A Reality Check. Journal of Crohn's and Colitis 2021. [DOI: 10.1093/ecco-jcc/jjab118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Konidari A, Dickens D, Pirmohamed M. Inflammatory Bowel Disease: A Personalized Approach. Front Pediatr 2020;8:620545. [PMID: 33643966 DOI: 10.3389/fped.2020.620545] [Reference Citation Analysis]
13 Martín-de-carpi J, Treviño SJ, Muncunill GP, Martín-masot R, Navas-lópez VM. Time to diagnosis in paediatric inflammatory bowel disease: Key points for an early diagnosis. Anales de Pediatría (English Edition) 2020;92:242.e1-9. [DOI: 10.1016/j.anpede.2019.11.004] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Murray FR, Morell B, Biedermann L, Schreiner P. Protein-losing enteropathy as precursor of inflammatory bowel disease: a review of the literature. BMJ Case Rep 2021;14:e238802. [PMID: 33431540 DOI: 10.1136/bcr-2020-238802] [Reference Citation Analysis]
15 Sulkanen E, Repo M, Huhtala H, Hiltunen P, Kurppa K. Impact of diagnostic delay to the clinical presentation and associated factors in pediatric inflammatory bowel disease: a retrospective study. BMC Gastroenterol 2021;21:364. [PMID: 34620103 DOI: 10.1186/s12876-021-01938-8] [Reference Citation Analysis]